Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels
一项 II 期前瞻性、开放标签随机对照试验,比较了对寡转移性前肠腺癌且循环肿瘤脱氧核糖核酸 (ctDNA) 水平无法检测的患者,采用标准治疗化疗联合或不联合序贯细胞减灭干预的疗效。
期刊:Annals of Surgical Oncology
影响因子:3.5
doi:10.1245/s10434-021-11249-7
Dhiman, Ankit; Vining, Charles C; Witmer, Hunter D D; Sood, Divya; Shergill, Ardaman; Kindler, Hedy; Roggin, Kevin K; Posner, Mitchell C; Ahmed, Osmanuddin S; Liauw, Stanley; Pitroda, Sean; Liao, Chih-Yi; Karrison, Theodore; Weichselbaum, Ralph; Polite, Blase; Eng, Oliver S; Catenacci, Daniel V T; Turaga, Kiran K